Details

Last Funding Type

Series B

Last Funding Money Raised

$103M

Industries

Biotechnology,Commercial,Health Care

Founded date

Jan 1, 2016

Number Of Employee

101 - 250

Operating Status

Active

Bit.bio specializes in the fields of coding and biology that determine the identity of every human cell. Their mission is coding cells for health. To do so, we apply the principles of computation to biology.

Bit.bio's current focus is to develop a scalable technology platform capable of producing consistent batches of every human cell. This has the potential to unlock a new generation of medicine: it will enable research and drug discovery to move on from inappropriate models and work with the cells that actually are affected by the human disease. A scalable platform of consistent cells will also be the basis for a new generation of cell and tissue therapies.

To achieve our goals, we have assembled a team of pioneers in stem cells, cellular reprogramming, mathematical modeling, and cell therapy.

Collaboration is at the heart of bit.bio. We are empirical, highly ambitious, and driven by a common purpose.